This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2002 May;23(5):240-5.

doi: 10.1016/s1471-4906(02)02180-4.

Tuning tumor-specific T-cell activation: a matter of costimulation?

Hinrich Abken¹, Andreas Hombach, Claudia Heuser, Kai Kronfeld, Barbara Seliger

Affiliations

PMID: 12102744
DOI: 10.1016/s1471-4906(02)02180-4

Review

Tuning tumor-specific T-cell activation: a matter of costimulation?

Hinrich Abken et al. Trends Immunol. 2002 May.

. 2002 May;23(5):240-5.

doi: 10.1016/s1471-4906(02)02180-4.

Authors

Hinrich Abken¹, Andreas Hombach, Claudia Heuser, Kai Kronfeld, Barbara Seliger

Affiliation

¹ Tumorgenetik, Klinik I für Innere Medizin, Universität zu Köln, D-50931 Köln, Germany. hinrich.abken@medizin.uni-koeln.de

PMID: 12102744
DOI: 10.1016/s1471-4906(02)02180-4

No abstract available

PubMed Disclaimer

Similar articles

The ups and downs of T cell costimulation.
Jenkins MK. Jenkins MK. Immunity. 1994 Sep;1(6):443-6. doi: 10.1016/1074-7613(94)90086-8. Immunity. 1994. PMID: 7534615 Review. No abstract available.
The Yin and Yang of T cell costimulation.
Allison JP, Krummel MF. Allison JP, et al. Science. 1995 Nov 10;270(5238):932-3. doi: 10.1126/science.270.5238.932. Science. 1995. PMID: 7481795 Review. No abstract available.
The complexity of the B7-CD28/CTLA-4 costimulatory pathway.
Schweitzer AN, Sharpe AH. Schweitzer AN, et al. Agents Actions Suppl. 1998;49:33-43. doi: 10.1007/978-3-0348-8857-8_6. Agents Actions Suppl. 1998. PMID: 9426826 Review.
New protein steals the show as 'costimulator' of T cells.
Cohen J. Cohen J. Science. 1993 Nov 5;262(5135):844-5. doi: 10.1126/science.7694360. Science. 1993. PMID: 7694360 No abstract available.
Absence of B7-dependent responses in CD28-deficient mice.
Green JM, Noel PJ, Sperling AI, Walunas TL, Gray GS, Bluestone JA, Thompson CB. Green JM, et al. Immunity. 1994 Sep;1(6):501-8. doi: 10.1016/1074-7613(94)90092-2. Immunity. 1994. PMID: 7534617

See all similar articles

Cited by

Mismatch repair gene defects in sporadic colorectal cancer enhance immune surveillance.
Scarpa M, Ruffolo C, Canal F, Scarpa M, Basato S, Erroi F, Fiorot A, Dall'Agnese L, Pozza A, Porzionato A, Castagliuolo I, Dei Tos AP, Bassi N, Castoro C. Scarpa M, et al. Oncotarget. 2015 Dec 22;6(41):43472-82. doi: 10.18632/oncotarget.6179. Oncotarget. 2015. PMID: 26496037 Free PMC article.
Temporal transcriptome changes induced by MDV in Marek's disease-resistant and -susceptible inbred chickens.
Yu Y, Luo J, Mitra A, Chang S, Tian F, Zhang H, Yuan P, Zhou H, Song J. Yu Y, et al. BMC Genomics. 2011 Oct 12;12:501. doi: 10.1186/1471-2164-12-501. BMC Genomics. 2011. PMID: 21992110 Free PMC article.
Induction of an antitumour adaptive immune response elicited by tumour cells expressing de novo B7-1 mainly depends on the anatomical site of their delivery: the dose applied regulates the expansion of the response.
Sartoris S, Testi MG, Stefani E, Chignola R, Guerriero C, Matucci A, Cestari T, Scarpa A, Riviera AP, Zanoni G, Tridente G, Andrighetto G. Sartoris S, et al. Immunology. 2003 Dec;110(4):474-81. doi: 10.1111/j.1365-2567.2003.01760.x. Immunology. 2003. PMID: 14632645 Free PMC article.
Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas.
Kruschinski A, Moosmann A, Poschke I, Norell H, Chmielewski M, Seliger B, Kiessling R, Blankenstein T, Abken H, Charo J. Kruschinski A, et al. Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17481-6. doi: 10.1073/pnas.0804788105. Epub 2008 Nov 5. Proc Natl Acad Sci U S A. 2008. PMID: 18987320 Free PMC article.
Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy.
Olguín-Contreras LF, Mendler AN, Popowicz G, Hu B, Noessner E. Olguín-Contreras LF, et al. Front Immunol. 2021 Nov 29;12:750478. doi: 10.3389/fimmu.2021.750478. eCollection 2021. Front Immunol. 2021. PMID: 34912334 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database